Alpha 2.0
Login Register
» Authors » John A Ormiston

John A Ormiston

Explore the profile of John A Ormiston including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 125
Citations 1631
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Pharmacology
General Medicine
Top 10 Co-Authors
Patrick W Serruys
Mark W I Webster
Leif Thuesen
Yoshinobu Onuma
Dariusz Dudek
Hector M Garcia-Garcia
Susan Veldhof
Dougal McClean
Robert Whitbourn
Bernard Chevalier
Published In
EuroIntervention
JACC Cardiovasc Interv
Catheter Cardiovasc Interv
Circ Cardiovasc Interv
J Am Coll Cardiol
Affiliations
Soon will be listed here.
Recent Articles
1.
The Polyzene-F Stent Coating Improves Healing and Outcomes Preclinically, but Is It Effective Clinically?
Ormiston J, White J
Cardiovasc Revasc Med . 2022 Jun; 41:81-82. PMID: 35710897
No abstract available.
2.
Proximal to Distal Y-Stent Deployment for Coronary Bifurcation Lesions: Procedure and Three-Year Clinical Outcomes
Ding P, George S, Ormiston J, Webber B, Dimalapang E, Webster M
J Invasive Cardiol . 2022 Apr; 34(5):E397-E407. PMID: 35451997
Aims: Percutaneous coronary intervention with Y-stenting of coronary bifurcation disease is not commonly undertaken. The procedural and medium-term clinical outcomes of coronary bifurcation lesions treated with the proximal to distal...
3.
Real-time intravascular ultrasound guidance: A novel technique for accurate placement of ostial stents
Harding S, Webber B, Fairley S, Ormiston J
Catheter Cardiovasc Interv . 2021 Jun; 99(3):699-705. PMID: 34132465
Objectives: To describe a novel technique for ostial stent placement using real-time IVUS guidance. Background: Accurate placement of coronary stents at ostial locations is challenging with the true ostium frequently...
4.
Critical aspects of balloon position during final proximal optimization technique (POT) in coronary bifurcation stenting
Andreasen L, Holm N, Webber B, Ormiston J
Catheter Cardiovasc Interv . 2020 Feb; 96(1):31-39. PMID: 32087046
Objectives: In a coronary bifurcation bench model, to determine the effects of side branch (SB) wire crossing position and balloon position on the stent scaffolding after the final proximal optimization...
5.
Mechanical properties of the drug-eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug-eluting stent
Barkholt T, Webber B, Holm N, Ormiston J
Catheter Cardiovasc Interv . 2019 Nov; 96(7):E674-E682. PMID: 31710149
Objectives: To compare on the bench the physical and mechanical properties of Magmaris, a magnesium bioresorbable scaffold (BRS), with Absorb and DESolve polymeric BRS and a permanent metallic stent. Background:...
6.
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions
Verheye S, Costa R, Schofer J, Ormiston J, Maeng M, Dudek D, et al.
EuroIntervention . 2018 Dec; 15(8):685-687. PMID: 30530403
No abstract available.
7.
The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
Katagiri Y, Serruys P, Macaya C, Ormiston J, Hill J, Lang I, et al.
JACC Cardiovasc Interv . 2018 May; 11(10):1013-1015. PMID: 29798767
No abstract available.
8.
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, et al.
EuroIntervention . 2018 Apr; 14(9):e1057-e1066. PMID: 29667581
Aims: This study sought to investigate the long-term clinical outcomes related to scaffold sizing based on quantitative coronary angiography. Methods And Results: A total of 1,248 patients who received Absorb...
9.
It seemed like a good idea at the time
Ormiston J, Webster M
EuroIntervention . 2018 Mar; 13(16):1876-1879. PMID: 29555619
No abstract available.
10.
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W, Vrolix M, Verheye S, Schoors D, Slagboom T, Gosselink M, et al.
EuroIntervention . 2017 Dec; 13(18):e2147-e2151. PMID: 29278354
Aims: The aim of this study was to evaluate the five-year clinical results of a sirolimus-eluting stent (MiStent SES) with a bioabsorbable coating designed for sustained drug delivery during and...